ANAHEIM, Calif., /PRNewswire-iReach/ -- Headquartered in Anaheim, California, WholeHealth Products is a diversified company comprised of several specialized partners focused on leveraging the power ...
Preliminary results with a point-of-care test developed to assess cardiac troponin I (cTnI) in saliva rather than blood have shown cTnl can be detected in the saliva of patients with proven myocardial ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single high-sensitivity troponin I test below 2 ng/L ...
TARRYTOWN, N.Y.--(BUSINESS WIRE)--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test 1 immediately advances care for at-risk cardiac patients in the ...
Please provide your email address to receive an email when new articles are posted on . Using a novel saliva-based rapid cardiac troponin I test to diagnose MI was feasible, according to the results ...
ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
Fullerton, CA - Beckman Coulter (Fullerton, CA), Inc has announced FDA approval of its Access® AccuTnI? test for cardiac troponin I. The test has been approved as an aid in the diagnosis and treatment ...
New preliminary research is suggesting a simple saliva test can detect the presence of a protein biomarker known to signal the occurrence of a heart attack in just 10 minutes. If this prototype test ...
If done with the right preparations, hospital systems can make the switch to high-sensitivity cardiac troponin (hs-cTn) assays for the evaluation of chest pain in the emergency department (ED) without ...
Abbott Laboratories' High-Sensitive Troponin-I blood test was the first to be given a CE mark in Europe last fall for the prediction of heart disease risk when used alongside other assessments. Now, a ...